Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03926598 · ClinicalTrials.gov registry record
Guide To Goals: A Novel Care Coordination Tool for Children With Type Two Diabetes (T2D)
A clinical trial of Type 2 Diabetes Mellitus, sponsored by Georgia Institute of Technology.
- Completed
- Registry status
- 6
- Enrollment target
- 1
- Study location
NCT03926598: Completed study of Type 2 Diabetes Mellitus, sponsored by Georgia Institute of Technology.
NCT03926598 is a study of Type 2 Diabetes Mellitus that has completed, run by Georgia Institute of Technology. The registered enrollment target is 6 participants, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03926598, a study of Type 2 Diabetes Mellitus, has completed, sponsored by Georgia Institute of Technology.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The ultimate goal of this field trial is to systematically evaluate a novel care coordination tool for children with Type 2 Diabetes (T2D) in an office setting at Emory/Childrens Healthcare of Atlanta. The Guide to Goals (GTG) application was designed and developed at Georgia Institute of Technology with the aim of providing evidence-based information in a timely manner to all the stakeholders involved in the care of a T2D patient during an office visit
Primary Outcome
Number of participants that complete all the tasks assigned to them during the intervention (usability testing session).
Conditions Studied
Interventions
- BEHAVIORAL Patient and/or Family Member Intervention
- BEHAVIORAL Certified Diabetes Educator Intervention
- BEHAVIORAL Physician Intervention
- BEHAVIORAL Front Desk Staff Intervention
- BEHAVIORAL Nurse Intervention
Study Locations (1)
Georgia
- Children's Helathcare of Atlanta - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-06-05 |
| Est. Completion | 2019-08-30 |
What the finished NCT03926598 record still lists
NCT03926598 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 5 interventions - of which Patient and/or Family Member Intervention is the first listed.
NCT03926598 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT03926598 about?
NCT03926598 is a clinical study titled "Guide To Goals: A Novel Care Coordination Tool for Children With Type Two Diabetes (T2D)". The ultimate goal of this field trial is to systematically evaluate a novel care coordination tool for children with Type 2 Diabetes (T2D) in an office setting at Emory/Childrens Healthcare of Atlanta. The Guide to Goals (GTG) application was designed and developed at Georgia Institute of Technology...
What is the current status of trial NCT03926598?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2019-06-05. Estimated completion is 2019-08-30.
What conditions does trial NCT03926598 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.
What interventions are being tested in trial NCT03926598?
The interventions under investigation include: Patient and/or Family Member Intervention (BEHAVIORAL), Certified Diabetes Educator Intervention (BEHAVIORAL), Physician Intervention (BEHAVIORAL), Front Desk Staff Intervention (BEHAVIORAL), Nurse Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03926598?
This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03926598 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03926598's enrollment target sits among peer trials
6 130th of 130 higher than 1 of 130 other Type 2 Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
RECRUITING
-
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
-
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
RECRUITING
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
RECRUITING
-
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI